ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 895,38
1,60%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Fulgent Genetics Inc (FLGT)

  7. Fulgent Genetics Inc (FLGT) Actualités

FLGT Fulgent Genetics Inc

21,50
0,26 (1,22%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Fulgent Genetics Inc FLGT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,26 1,22% 21,50 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
20,50 20,50 21,60 21,50 21,24
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/5/202413:00BWFulgent Reports First Quarter 2024 Financial Results
11/4/202422:05BWFulgent Genetics to Announce First Quarter 2024 Financial..
05/3/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202413:08EDGAR2Form 8-K - Current report
28/2/202413:00BWFulgent Reports Fourth Quarter and Full Year 2023 Financial..
28/2/202400:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202414:00BWFulgent Genetics to Announce Fourth Quarter and Full Year..
10/2/202400:09EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
09/2/202414:31PRNUSCord Blood Registry® (CBR®) by CooperSurgical® and Fulgent..
07/2/202401:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202302:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202303:43EDGAR2Form 144 - Report of proposed sale of securities
07/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202300:13EDGAR2Form 144 - Report of proposed sale of securities
05/12/202300:12EDGAR2Form 144 - Report of proposed sale of securities
20/11/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202303:21EDGAR2Form 144 - Report of proposed sale of securities
14/11/202322:30BWFulgent to Participate in the Piper Sandler 35th Annual..
07/11/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:05BWFulgent Shares Data from Two Poster Presentations at SITC..
03/11/202312:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202312:09EDGAR2Form 8-K - Current report
03/11/202312:00BWFulgent Reports Third Quarter 2023 Financial Results
01/11/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202322:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202314:00BWFulgent Announces Two Poster Presentations at SITC 2023..
17/10/202314:00BWFulgent Genetics to Announce Third Quarter 2023 Financial..
11/9/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202301:00EDGAR2Form 144 - Report of proposed sale of securities
21/8/202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202322:54EDGAR2Form 144 - Report of proposed sale of securities
16/8/202322:51EDGAR2Form 144 - Report of proposed sale of securities
07/8/202323:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202313:07EDGAR2Form 8-K - Current report
04/8/202313:00BWFulgent Reports Second Quarter 2023 Financial Results
03/8/202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202322:05GLOBEExagen Inc. Appoints Paul Kim to Board of Directors
18/7/202314:00BWFulgent Genetics to Announce Second Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
FLGT
Fulgent Genetics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés